Glaxo Wellcome

Glaxo SmithKline reaches agreement with US FTC

By | 18 Dec 2000

Glaxo''s Relenza gets UK approval

21 Nov 2000

Glaxo to push ahead with Ziagen in Europe

08 Mar 2000

Featured articles

Lighter than air, yet very, very powerful

By Kiron Kasbekar | 03 Jan 2024

In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!

COP28 explained: A closer look at COP28's climate change solutions

By Aniket Gupta | 27 Dec 2023

The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.

What is a Ponzi scheme?

By Aniket Gupta | 06 Dec 2023

Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.

The Rise and Rise of HDFC Bank

03 Jul 2023

HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp

India’s Millet Revolution To Enrich Global Food Basket

02 Apr 2023

Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent 

Market predator Hindenburg preys on Adani stock

06 Mar 2023

Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation